UPMC Enterprises Invests in Predictive Analytics Startup RxAnte | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

UPMC Enterprises Invests in Predictive Analytics Startup RxAnte

October 7, 2016
by Heather Landi
| Reprints

Portland, Maine-based predictive analytics company RxAnte has received a growth equity investment from UPMC Enterprises, the commercialization arm of the UPMC health system in Pittsburgh.

Under the terms of the transaction closed on Sept. 30, Millennium Health sold its entire interest in RxAnte, which will continue to operate as an independent company, led by its existing management team. 

Founded in 2011, RxAnte’s technology and clinical services focus on solutions to improve the use of prescription medications. The investment by UPMC Enterprises will facilitate product development in collaboration with clinical experts at UPMC and accelerate growth, according to a UPMC press release.

The UPMC Health Plan has been a customer of RxAnte for the past three years. According to UPMC officials, use of RxAnte’s solutions have optimized medication use, saving excess medical costs and directly contributing to the plan’s superior Star Rating performance on medication adherence measures by the Centers for Medicare & Medicaid Services (CMS).

“RxAnte’s technology and services have been a key driver of our stellar performance in ensuring that our members receive the appropriate medications for their conditions, leading to better patient outcomes and effective cost management,” William Shrank, M.D., chief medical officer for the UPMC Insurance Services Division, said in a statement. “With UPMC’s clinical expertise and the Health Plan’s strength in analytics, we look forward to supporting RxAnte’s product development and advancing our joint goal of providing the highest value from prescription medications.”

RxAnte currently manages medication use for nearly 7 million people on behalf of health insurers, providers and other stakeholders confronting the challenge of improving safe and effective prescription drug use.

RxAnte’s priorities with this new investment include expanding its offerings for Medicare, Medicaid and commercial populations, with particular focus on analytics and clinical programs that lower total cost of care. The company also intends to extend its predictive models and workflow tools to the management of high-cost specialty drugs.

 “Improving medication use is increasingly recognized as one of the biggest but most challenging opportunities to improve patient outcomes while reducing health care costs,” Tal Heppenstall, president of UPMC Enterprises, said.

Josh Benner, founder and chief executive officer of RxAnte, said in a prepared statement, “This is a major milestone for RxAnte that will expand the breadth and depth of the analytics and population health management solutions we provide.”

Get the latest information on Healthcare Analytics and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Health Sciences South Carolina Wins ‘Best in Show’ at FHIR Applications Roundtable

At the HL7 FHIR Applications Roundtable held in New Orleans in December, Health Sciences South Carolina (HSSC) was voted Best in Show for its clinical data repository for South Carolina hospitals.

2018 Most Influential Women in Health IT Awardees Announced

Four healthcare IT leaders—Ann O’Brien, R.N., Judy Murphy, R.N., Jessica Kahn and Vice Admiral Raquel C. Bono—have been named as the 2018 awardees of HIMSS’ Most Influential Women in Health IT.

Reports: DoD-Cerner EHR Rollout Postponed for 8 Weeks

The Department of Defense (DoD) and Cerner are suspending their MHS Genesis electronic health record (EHR) modernization project for eight weeks, according to multiple media reports.

Change Healthcare Announces Availability of Enterprise-Scale Blockchain Solution

Executives from Nashville-based Change Healthcare have announced that its Intelligent Healthcare Network with blockchain is now available featuring claims management transparency, attesting that it is the first enterprise-scale blockchain in healthcare.

Health IT Experts Join Health Catalyst Team

Salt Lake City-based healthcare data analytics company Health Catalyst has added three health IT and quality heavyweights as strategic advisors.

Rock Health: Digital Health Venture Funding Reached $5.8B in 2017

Digital health venture funding in 2017 approached $6 billion and had the most mega deals ($100 million+) to date, according to a year-end report from San Francisco-based Rock Health.